NEUROCRINE BIOSCIENCES INC (NBIX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350M 700M 1.1B Q3 '16: 0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 6.3M Q3 '17: 60.8M Q4 '17: 94.5M Q1 '18: 71.1M Q2 '18: 96.9M Q3 '18: 151.8M Q4 '18: 131.5M Q1 '19: 138.4M Q2 '19: 183.5M Q3 '19: 222.1M Q4 '19: 244.1M Q1 '20: 237.1M Q2 '20: 302.4M Q3 '20: 258.5M Q4 '20: 247.9M Q1 '21: 236.6M Q2 '21: 288.9M Q3 '21: 296M Q4 '21: 312M Q1 '22: 310.6M Q2 '22: 378.2M Q3 '22: 387.9M Q4 '22: 412M Q1 '23: 420.4M Q2 '23: 452.7M Q3 '23: 498.8M Q4 '23: 515.2M Q1 '24: 515.3M Q2 '24: 590.2M Q3 '24: 622.1M Q4 '24: 627.7M Q1 '25: 572.6M Q2 '25: 687.5M Q3 '25: 794.9M Q4 '25: 805.5M Q1 '26: 814.5M Q2 '26: 959M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 350M 700M 1.1B Q2 '25: 670.9M Q2 '26: 927.4M Q2 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-180M -90M 0 90M 180M 270M Q2 '16: -41.8M Q3 '16: -38.4M Q4 '16: -46.3M Q1 '17: -79.9M Q2 '17: -57.3M Q3 '17: -6M Q4 '17: 11.8M Q1 '18: -37.4M Q2 '18: -1.9M Q3 '18: 54.3M Q4 '18: 21.8M Q1 '19: -101M Q2 '19: 34.4M Q3 '19: 90.1M Q4 '19: 48.8M Q1 '20: 58.9M Q2 '20: 76.6M Q3 '20: -44.3M Q4 '20: 71.8M Q1 '21: 31.5M Q2 '21: 62.8M Q3 '21: 44.5M Q1 '22: 3.1M Q2 '22: 54.7M Q3 '22: 87.8M Q4 '22: 103.4M Q1 '23: -114.2M Q2 '23: 73.6M Q3 '23: 141.2M Q4 '23: 150.3M Q1 '24: 99.3M Q2 '24: 145.4M Q3 '24: 183.8M Q4 '24: 142M Q1 '25: 23.6M Q2 '25: 145.6M Q3 '25: 239M Q4 '25: 210.9M Q1 '26: 193.4M Q2 '26: 151.5M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-150M 0 150M 300M 450M Q2 '16: -40.3M Q3 '16: -36.9M Q4 '16: -44.7M Q1 '17: -78.3M Q2 '17: -60M Q3 '17: -11.1M Q4 '17: 6.9M Q1 '18: -41.8M Q2 '18: -5.9M Q3 '18: 50.8M Q4 '18: 18.1M Q1 '19: -102.1M Q2 '19: 51.3M Q3 '19: 53.8M Q4 '19: 34M Q1 '20: 37.4M Q2 '20: 79.6M Q3 '20: -57.6M Q4 '20: 347.9M Q1 '21: 32.1M Q2 '21: 42.3M Q3 '21: 22.5M Q1 '22: 13.9M Q2 '22: -16.9M Q3 '22: 68.5M Q4 '22: 89M Q1 '23: -76.6M Q2 '23: 95.5M Q3 '23: 83.1M Q4 '23: 147.7M Q1 '24: 43.4M Q2 '24: 65M Q3 '24: 129.8M Q4 '24: 103.1M Q1 '25: 7.9M Q2 '25: 107.5M Q3 '25: 209.5M Q4 '25: 153.7M Q1 '26: 197.9M Q2 '26: 144.4M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 8M 16M 24M Q2 '17: 61K Q3 '17: 433K Q4 '17: 760K Q1 '18: 950K Q2 '18: 854K Q3 '18: 1.6M Q4 '18: 1.5M Q1 '19: 1.1M Q2 '19: 1.6M Q3 '19: 2.2M Q1 '20: 2.1M Q2 '20: 2.4M Q3 '20: 2.7M Q4 '20: 2.9M Q1 '21: 2.9M Q2 '21: 3.1M Q3 '21: 4.2M Q4 '21: 4.1M Q1 '22: 4.6M Q2 '22: 4.8M Q3 '22: 6.1M Q4 '22: 7.7M Q1 '23: 8.5M Q2 '23: 11.5M Q3 '23: 11.2M Q4 '23: 8.5M Q1 '24: 7.5M Q2 '24: 9.2M Q3 '24: 8M Q4 '24: 9.3M Q1 '25: 9.2M Q2 '25: 11.3M Q3 '25: 14M Q4 '25: 17.6M Q1 '26: 13.8M Q2 '26: 23.2M Q2 '17 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-150M 0 150M 300M 450M Q3 '16: -31M Q4 '16: -31.6M Q1 '17: -77.4M Q2 '17: -48.2M Q3 '17: -9.3M Q4 '17: 40.6M Q1 '18: -38.5M Q2 '18: 20.5M Q3 '18: 68.9M Q4 '18: 50.5M Q1 '19: -112.5M Q2 '19: 64.2M Q3 '19: 97.8M Q4 '19: 97.5M Q1 '20: 35.5M Q2 '20: 118.9M Q3 '20: -20.4M Q4 '20: 94.5M Q1 '21: 87.3M Q2 '21: 103.2M Q3 '21: 61.8M Q4 '21: 4.2M Q1 '22: -40.5M Q2 '22: 138.1M Q3 '22: 98.8M Q4 '22: 143M Q1 '23: -125.2M Q2 '23: 179.6M Q3 '23: 212M Q4 '23: 123.5M Q1 '24: 130.3M Q2 '24: 64.6M Q3 '24: 158M Q4 '24: 242.5M Q1 '25: 64.8M Q2 '25: 102M Q3 '25: 227.5M Q4 '25: 388.4M Q1 '26: 145.8M Q2 '26: 136.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-160M -80M 0 80M 160M 240M Q2 '16: -16.6M Q3 '16: -31.8M Q4 '16: -32M Q1 '17: -78.7M Q2 '17: -48.6M Q3 '17: -12.1M Q4 '17: 38.2M Q1 '18: -40.3M Q2 '18: 15.8M Q3 '18: 56.6M Q4 '18: 44.5M Q1 '19: -116.4M Q2 '19: 59.7M Q3 '19: 94.3M Q4 '19: 94.7M Q1 '20: 34.2M Q2 '20: 114.2M Q3 '20: -20.8M Q4 '20: 90M Q1 '21: 82.8M Q2 '21: 98.9M Q3 '21: 56.1M Q4 '21: -4.7M Q1 '22: -48.1M Q2 '22: 129.3M Q3 '22: 97.1M Q4 '22: 141.2M Q1 '23: -133.7M Q2 '23: 172.8M Q3 '23: 204.4M Q4 '23: 118.1M Q1 '24: 119.1M Q2 '24: 53M Q3 '24: 149.9M Q4 '24: 235.2M Q1 '25: 54.1M Q2 '25: 89.5M Q3 '25: 214.3M Q1 '26: 136.7M Q2 '26: 128.6M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '12: 66.3M Q3 '12: 66.3M Q4 '12: 67.7M Q1 '13: 66.6M Q2 '13: 66.8M Q3 '13: 67.2M Q4 '13: 67.3M Q1 '17: 87.3M Q2 '17: 88.1M Q3 '17: 88.3M Q4 '17: 92.7M Q1 '18: 89.5M Q2 '18: 90.1M Q3 '18: 96.8M Q4 '18: 95.7M Q1 '19: 91.1M Q2 '19: 94.8M Q3 '19: 96.1M Q4 '19: 97.2M Q1 '20: 97M Q2 '20: 98.2M Q3 '20: 93.3M Q4 '20: 97.2M Q1 '21: 98.2M Q2 '21: 97.7M Q3 '21: 97.7M Q1 '22: 97.6M Q2 '22: 95.6M Q3 '22: 99M Q1 '23: 97.1M Q2 '23: 100.2M Q3 '23: 101.1M Q1 '24: 103.6M Q2 '24: 103.9M Q3 '24: 104.3M Q1 '25: 102.5M Q2 '25: 101M Q3 '25: 102.5M Q1 '26: 103.4M Q2 '26: 104.2M Q2 '13 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-5.00 -2.50 0.00 2.50 5.00 7.50 Q3 '15: -0.95 Q4 '15: -1.03 Q1 '16: -1.24 Q2 '16: -1.42 Q3 '16: -1.45 Q4 '16: -1.62 Q1 '17: -2.30 Q2 '17: -2.52 Q3 '17: -2.22 Q4 '17: -1.64 Q1 '18: -1.21 Q2 '18: -0.60 Q3 '18: 0.05 Q4 '18: 0.17 Q1 '19: -0.48 Q2 '19: 0.13 Q3 '19: 0.17 Q4 '19: 0.33 Q1 '20: 1.84 Q2 '20: 2.11 Q3 '20: 0.93 Q4 '20: 4.16 Q1 '21: 4.10 Q2 '21: 3.72 Q3 '21: 4.57 Q4 '22: 1.54 Q1 '23: 0.61 Q2 '23: 1.74 Q3 '23: 1.87 Q4 '23: 2.44 Q1 '24: 3.65 Q2 '24: 3.33 Q3 '24: 3.75 Q4 '24: 3.29 Q1 '25: 2.95 Q2 '25: 3.38 Q3 '25: 4.18 Q4 '25: 4.66 Q1 '26: 6.49 Q2 '26: 6.82 Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.